Crossmark

Antiplatelet effect of cudraxanthone B is related to inhibition of calcium mobilization, αIIbβ3 activation, and clot retraction

Published Online: 2021-01-12

Published Print: 2021-12

Authors

Shin, Jung-Hae

Irfan, Muhammad

Rhee, Man Hee

Kwon, Hyuk-Woo http://orcid.org/0000-0001-6228-2814
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2018R1C1B5083580)
License Information

Text and Data Mining valid from 2021-01-12

Version of Record valid from 2021-01-12
More Information

Article History

Received: 24 September 2020

Accepted: 2 December 2020

First Online: 12 January 2021

Competing interest

: The authors declare no conflict of interest.

Document is current